AzTrials
AzTrials

Preoperative FastingNCT06522204

Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children

A study testing %5 Dextrose in people with Preoperative Fasting, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In the recent literature, preoperative fasting times for pediatric patients are limited to one hour for clear fluids. Studies related to gastric emptying times mostly searched for normal-weight children. These studies have claimed that 3 mL/kg of clear liquid can be allowed up to 1 hour before surgery. Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Preoperative Fasting
What is being tested?
%5 Dextrose
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Jul 2024to 15 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • ASA physical state I or II
  • Age 6 to 14 years.
  • Gender: both sexes.
  • Scheduled for non-gastrointestinal Tract elective day-case surgery under general anesthesia.

Who cannot join

  • Parent/caregiver refusal
  • Ages < 6 or > 14 years old
  • Children with gastroesophageal reflux disease
  • Renal failure
  • Diabetes mellitus
  • Cerebral palsy patients
Show all 12Show fewer
  • Mental retardation
  • Esophageal strictures, achalasia, or any intestinal disease that may impair gastric emptying.
  • Gastrointestinal system surgery and neurosurgical patients
  • Emergency surgery
  • Violation of the prescribed fasting times
  • Refusing to drink prescribed clear fluid

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karaman Training and Research Hospital

    Karaman

Other trials in Turkey (Türkiye)

About this study

Official title: Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children After Preoperative Precise Fluid Intake

In the recent literature, preoperative fasting times for pediatric patients are limited to one hour for clear fluids. Studies related to gastric emptying times mostly searched for normal-weight children. These studies have claimed that 3 mL/kg of clear liquid can be allowed up to 1 hour before surgery. There is a lack of interest in the gastric emptying time of underweight pediatric patients during the preoperative period. Recent studies suggest that underweight children may experience rapid gastric emptying. This trial compares the gastric volume and emptying time after ingesting 3 mL/kg clear fluid in underweight and normal-weight pediatric patients in the preoperative period.

Read the detailed description

After receiving informed consent from the children and their families, the American Society of Anesthesiologists (ASA) 1-2 pediatric patients between 6 and 14 years who will be recruited for elective surgery will be included in this study. The children under the 5% percentile will be accepted as underweight. After, the basal gastric volume will be calculated with the help of Ultrasonography (USG). The children will receive oral 3 mL/kg 5% dextrose. USG evaluation will be made every 5 minutes until the gastric volume reaches the basal level. Children reaching basal gastric volume will be accepted as suitable for the surgery. This study compares the gastric volume and emptying time after ingesting 3 mL/kg clear fluid in underweight and average-weight pediatric patients in the pre-operative period.

Being tested
%5 Dextrose
Keywords
gastric empyting, gastric volume, ultrasonography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • %5 DextroseDrug

    Also called Group U, Group N

    All the patients will receive oral 3mL/kg 5%Dextrose

Study groups in NCT06522204
Study groupRoleWhat they receive
Grup UnderweightExperimentalExperimental: Underweight pediatric patient Underweight children aged 6-14 years, under 5% percentile, fasted for the night before planned surgery.
Receives: Drug: %5 Dextrose
Group Normal weightActive comparatorActive Comparator: Normal weight pediatric patient Normal weight children aged 6-14 years, between 5-85% percentile, fasted for the night before planned surgery.
Receives: Drug: %5 Dextrose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gastric emptying time

    Time until the gastric volume reaches the baseline level again

    Measured: 90 minute after Dextrose ingestion

Secondary outcomes (1)
  1. Antral cross-sectional area

    Antral cross-Section Area (ACSA) (cm2) maximal anteroposterior diameter (D1) and longitudinal diameter (D2) will be measured with ultrasound and calculated with that mathematical formula:

    ACSA(cm2) = Π x D1 x D2 / 4

    Measured: Every 5 minute until the ACSA decreased to the baseline value (assessed up to 90 minute after Dextrose ingestion).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2024
  2. Study start30 Jul 2024
  3. Primary completion15 Dec 2025
  4. Study completion15 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Pediatric patients will be divided into two groups as underweight and normal weight. Children under the % percentile will be considered as underweight.
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06522204
Sponsor's protocol ID
09-2023/11
Status last verified
Dec 2025
First submitted
16 Jul 2024
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing %5 Dextrose in people with Preoperative Fasting, run by Karaman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gastric emptying time (time frame: 90 minute after Dextrose ingestion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in